Tuesday, January 19, 2016

Illumina Makes Another Investment In Twist Bioscience

San Diego-based life sciences maker Illumina has participated in another investment round for San Francisco-based DNA synthesis startup Twist Bioscience, in a new Series D funding for that company. Twist announced a $61M Series D financing and a $20M debt funding round today, which was led by ARCH Overage Fund, Merieux Developpement, Cormorant Asset Management LLC, Fidelity Management and Research Company and Foresite Capital Management LLC, and also included ARCH Venture Partners, WuXi Corporate Venture Fund, Illumina, Inc., Nick and Joby Pritzker (via Tao Invest), Paladin Capital Group, Yuri Milner, Boris Nikolic, plus others. The debt funding came from Silicon Valley Bank. Illumina also participated in Twist Bioscience's Series C funding, announced in June of 2015. More information »